Clinical Trial

Assessing the Prevalence and Epidemiological Characteristics of Small Intestinal Bacterial Overgrowth (SIBO) in Patients With Autoimmune Gastritis(AIG) Through Hydrogen and Methane Breath Testing(HMBT).

Study acronym: HMBT、SIBO、AIG
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated April 27, 2025 (before its estimated December 31, 2025 completion). Its status may not reflect the trial's current state.
Summary
Evaluate the prevalence of small intestinal bacterial overgrowth in patients with autoimmune gastritis (AIG) through hydrogen and methane breath testing, and determine whether there are differences in the positive rates of hydrogen and methane breath testing among the AIG group, the acid suppression group, and the control group.
Trial Details
NCT Number NCT06946706
Lead Sponsor RenJi Hospital
Conditions Autoimmune Gastritis
Enrollment 220 participants
Start Date 2025-01-06
Primary Completion 2025-12-31 (estimated)
Study Completion 2026-06-30 (estimated)
Updated on ClinicalTrials.gov 2025-04-27